A critical advance in cancer investigation is occurring with the use of mini-antibodies to re-engage mutated p53. This crucial tumor inhibitor protein is frequently disabled in several forms of cancer, resulting https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research